These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26749694)

  • 1. [Vaccination against yellow fever: lifetime protection?].
    Leroy JP
    Rev Prat; 2015 Oct; 65(8):1015-7. PubMed ID: 26749694
    [No Abstract]   [Full Text] [Related]  

  • 2. Yellow fever: a global reckoning.
    The Lancet
    Lancet; 2016 Apr; 387(10026):1348. PubMed ID: 27115797
    [No Abstract]   [Full Text] [Related]  

  • 3. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever vaccine as a vehicle to better travel medicine.
    Spira A
    J Travel Med; 2005; 12(6):303-5. PubMed ID: 16343380
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever.
    Chen LH; Hamer DH
    JAMA; 2017 Nov; 318(17):1651-1652. PubMed ID: 28983553
    [No Abstract]   [Full Text] [Related]  

  • 6. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional dosing of yellow fever vaccine during shortages: perspective from Canada.
    Teitelbaum P; Bui YG; Libman M; McCarthy A
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346564
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations for travellers during the yellow fever outbreaks in Brazil-2018.
    Fujita DM; da Silva Nali LH; Salvador FS; de Andrade Júnior HF
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29635644
    [No Abstract]   [Full Text] [Related]  

  • 9. No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?
    Wyplosz B; Leroy JP; Derradji O; Consigny PH
    J Travel Med; 2015; 22(2):140-1. PubMed ID: 25384441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yellow fever in Brazil: Epidemiological aspects and implications for travelers.
    Chaves TDSS; Orduna T; Lepetic A; Macchi A; Verbanaz S; Risquez A; Perret C; Echazarreta S; Rodríguez-Morales AJ; Lloveras SC
    Travel Med Infect Dis; 2018; 23():1-3. PubMed ID: 29751132
    [No Abstract]   [Full Text] [Related]  

  • 11. Pandemic yellow fever: a potential threat to global health via travelers.
    Gubler DJ
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30299494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas].
    Dabrowska MM; Flisiak R
    Przegl Epidemiol; 2010; 64(2):319-22. PubMed ID: 20731245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever – prevention in travellers.
    Arya SC
    Aust Fam Physician; 2010 Nov; 39(11):811. PubMed ID: 21387857
    [No Abstract]   [Full Text] [Related]  

  • 15. A Belgian traveler who acquired yellow fever in the Gambia.
    Colebunders R; Mariage JL; Coche JC; Pirenne B; Kempinaire S; Hantson P; Van Gompel A; Niedrig M; Van Esbroeck M; Bailey R; Drosten C; Schmitz H
    Clin Infect Dis; 2002 Nov; 35(10):e113-6. PubMed ID: 12410495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever - prevention in travellers.
    Neilson AA; Mayer CA
    Aust Fam Physician; 2010 Aug; 39(8):570-3. PubMed ID: 20877751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why immunisation is essential for controlling yellow fever.
    Skeet J
    Nurs Times; 2006 Apr 25-May 1; 102(17):52-3. PubMed ID: 16700237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rarity of adverse effects after 17D yellow-fever vaccination.
    Marianneau P; Georges-Courbot M; Deubel V
    Lancet; 2001 Jul; 358(9276):84-5. PubMed ID: 11463403
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of yellow fever in travellers: an update.
    Reno E; Quan NG; Franco-Paredes C; Chastain DB; Chauhan L; Rodriguez-Morales AJ; Henao-Martínez AF
    Lancet Infect Dis; 2020 Jun; 20(6):e129-e137. PubMed ID: 32386609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow fever: 100 years of discovery.
    Staples JE; Monath TP
    JAMA; 2008 Aug; 300(8):960-2. PubMed ID: 18728272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.